- Patent Title: CD6 antibody for treatment of T-cell mediated diseases or disorders
-
Application No.: US15623729Application Date: 2017-06-15
-
Publication No.: US10562975B2Publication Date: 2020-02-18
- Inventor: Feng Lin , David A. Fox
- Applicant: THE CLEVELAND CLINIC FOUNDATION , THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Applicant Address: US MI Ann Arbor US OH Cleveland
- Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN,THE CLEVELAND CLINIC FOUNDATION
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN,THE CLEVELAND CLINIC FOUNDATION
- Current Assignee Address: US MI Ann Arbor US OH Cleveland
- Agency: Tarolli, Sundheim, Covell & Tummino LLP
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
A method of treating a T-cell mediated disease in a subject by administering to the subject a therapeutically effective amount of an antibody or fragment thereof that specifically binds to CD6 is described. Humanized antibodies useful for the method are also described.
Public/Granted literature
- US20170362331A1 CD6 ANTIBODY FOR TREATMENT OF T-CELL MEDIATED DISEASES OR DISORDERS Public/Granted day:2017-12-21
Information query
